Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 198

1.

[CAPNETZ. The competence network for community-acquired pneumonia (CAP)].

Suttorp N, Welte T, Marre R, Stenger S, Pletz M, Rupp J, Schütte H, Rohde G; CAPNETZ-Studiengruppe.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Apr;59(4):475-81. doi: 10.1007/s00103-016-2318-7. German.

PMID:
26984399
2.

Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia.

Ewig S, Hecker H, Suttorp N, Marre R, Welte T; CAPNETZ study group.

J Infect. 2011 Mar;62(3):218-25. doi: 10.1016/j.jinf.2011.01.009. Epub 2011 Jan 27.

PMID:
21276814
3.

How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia.

von Baum H, Schweiger B, Welte T, Marre R, Suttorp N, Pletz MW, Ewig S; CAPNETZ Study Group.

Eur Respir J. 2011 May;37(5):1151-7. doi: 10.1183/09031936.00037410. Epub 2010 Sep 3.

4.
5.

Assessment of inflammatory markers in patients with community-acquired pneumonia--influence of antimicrobial pre-treatment: results from the German competence network CAPNETZ.

Krüger S, Ewig S, Kunde J, Hartmann O, Marre R, Suttorp N, Welte T; CAPNETZ study group.

Clin Chim Acta. 2010 Dec 14;411(23-24):1929-34. doi: 10.1016/j.cca.2010.08.004. Epub 2010 Aug 7.

PMID:
20699094
6.

Guidelines of the Paul-Ehrlich-Society of Chemotherapy, the German Respiratory Diseases Society, the German Infectious Diseases Society and of the Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia.

Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H; Paul-Ehrlich-Society of Chemotherapy; German Respiratory Diseases Society; German Infectious Diseases Society; Competence Network CAPNETZ for the Management of Lower Respiratory Tract Infections and Community-acquired Pneumonia.

Pneumologie. 2010 Mar;64(3):149-54. doi: 10.1055/s-0029-1243910. Epub 2010 Feb 23. No abstract available.

7.

[Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults].

Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H.

Dtsch Med Wochenschr. 2010 Feb;135(8):359-65. doi: 10.1055/s-0030-1249171. Epub 2010 Feb 17. German. No abstract available.

PMID:
20166002
8.

[Epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults. Guidelines of the Paul-Ehrlich-Society for Chemotherapy, the German Respiratory Society, the German Society for Infectiology and the Competence Network CAPNETZ Germany].

Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H; Paul-Ehrlich-Gesellschaft für Chemotherapie; Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin; Deutschen Gesellschaft für Infektiologie und vom Kompetenznetzwerk CAPNETZ.

Pneumologie. 2009 Oct;63(10):e1-68. doi: 10.1055/s-0029-1215037. Epub 2009 Oct 9. German. No abstract available.

9.

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: Diagnosis, incidence and predictors.

von Baum H, Welte T, Marre R, Suttorp N, Ewig S; CAPNETZ study group.

Eur Respir J. 2010 Mar;35(3):598-605. doi: 10.1183/09031936.00091809. Epub 2009 Aug 13.

10.

Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

Krüger S, Ewig S, Papassotiriou J, Kunde J, Marre R, von Baum H, Suttor N, Welte T; CAPNETZ Study Group.

Respir Res. 2009 Jul 12;10:65. doi: 10.1186/1465-9921-10-65.

11.

Mycoplasma pneumoniae pneumonia revisited within the German Competence Network for Community-acquired pneumonia (CAPNETZ).

von Baum H, Welte T, Marre R, Suttorp N, Lück C, Ewig S.

BMC Infect Dis. 2009 May 13;9:62. doi: 10.1186/1471-2334-9-62.

12.

C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.

Krüger S, Ewig S, Kunde J, Hanschmann A, Marre R, Suttorp N, Welte T; CAPNETZ Study Group.

J Antimicrob Chemother. 2009 Jul;64(1):159-62. doi: 10.1093/jac/dkp148. Epub 2009 Apr 29.

PMID:
19403654
13.

Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.

Tessmer A, Welte T, Martus P, Schnoor M, Marre R, Suttorp N.

J Antimicrob Chemother. 2009 May;63(5):1025-33. doi: 10.1093/jac/dkp088. Epub 2009 Mar 17.

PMID:
19293196
14.
15.

Community-acquired Legionella pneumonia: new insights from the German competence network for community acquired pneumonia.

von Baum H, Ewig S, Marre R, Suttorp N, Gonschior S, Welte T, Lück C; Competence Network for Community Acquired Pneumonia Study Group.

Clin Infect Dis. 2008 May 1;46(9):1356-64. doi: 10.1086/586741.

PMID:
18419436
16.

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment.

Kothe H, Bauer T, Marre R, Suttorp N, Welte T, Dalhoff K; Competence Network for Community-Acquired Pneumonia study group.

Eur Respir J. 2008 Jul;32(1):139-46. doi: 10.1183/09031936.00092507. Epub 2008 Feb 20.

17.

Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany.

Raum E, Lietzau S, von Baum H, Marre R, Brenner H.

Clin Microbiol Infect. 2008 Jan;14(1):41-8. Epub 2007 Nov 13.

18.

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.

Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T; CAPNETZ Study Group.

Eur Respir J. 2008 Feb;31(2):349-55. Epub 2007 Oct 24.

19.

[Interobserver agreement in the assessment of pulmonary infiltrates on chest radiography in community-acquired pneumonia].

Pauls S, Krüger S, Richter K, Muche R, Marre R, Welte T, Billich C, Gonschior S, Schumann C, Boll D, Aschoff AJ, Suttorp N.

Rofo. 2007 Nov;179(11):1152-8. German.

PMID:
17948193
20.

Pro-atrial natriuretic peptide and pro-vasopressin to predict severity and prognosis in community-acquired pneumonia: results from the German competence network CAPNETZ.

Krüger S, Papassotiriou J, Marre R, Richter K, Schumann C, von Baum H, Morgenthaler NG, Suttorp N, Welte T; CAPNETZ Study Group.

Intensive Care Med. 2007 Dec;33(12):2069-78. Epub 2007 Oct 16.

PMID:
17938883
21.

Household contacts were key factor for children's colonization with resistant Escherichia coli in community setting.

Lietzau S, Raum E, von Baum H, Marre R, Brenner H.

J Clin Epidemiol. 2007 Nov;60(11):1149-55. Epub 2007 Jul 25.

PMID:
17938057
22.

Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations.

Erb A, Stürmer T, Marre R, Brenner H.

Eur J Clin Microbiol Infect Dis. 2007 Feb;26(2):83-90. Review.

PMID:
17235554
23.

Antibiotic treatment of community acquired pneumonia varies widely across Germany.

Kohlhammer Y, Raspe H, Marre R, Suttorp N, Welte T, Schäfer T; CAPNETZ study group.

J Infect. 2007 May;54(5):446-53. Epub 2006 Sep 26.

PMID:
17007933
24.

Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia.

Wellinghausen N, Straube E, Freidank H, von Baum H, Marre R, Essig A.

Int J Med Microbiol. 2006 Nov;296(7):485-91. Epub 2006 Aug 4.

PMID:
16890487
25.

Moxifloxacin prophylaxis in neutropenic patients.

von Baum H, Sigge A, Bommer M, Kern WV, Marre R, Döhner H, Kern P, Reuter S.

J Antimicrob Chemother. 2006 Oct;58(4):891-4. Epub 2006 Jul 30.

PMID:
16880172
26.

Clustering of antibiotic resistance of E. coli in couples: suggestion for a major role of conjugal transmission.

Lietzau S, Raum E, von Baum H, Marre R, Brenner H.

BMC Infect Dis. 2006 Jul 18;6:119.

27.

Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples.

Dumke R, Lück PC, Noppen C, Schaefer C, von Baum H, Marre R, Jacobs E.

J Clin Microbiol. 2006 Jul;44(7):2567-70.

28.

CRB-65 predicts death from community-acquired pneumonia.

Bauer TT, Ewig S, Marre R, Suttorp N, Welte T; CAPNETZ Study Group.

J Intern Med. 2006 Jul;260(1):93-101.

29.

[What is new in the treatment of community-acquired pneumonia?].

Welte T, Marre R, Suttorp N; Kompetenznetzwerk "Ambulant Erworbene Pneumonie" (CAPNETZ).

Med Klin (Munich). 2006 Apr 15;101(4):313-20. Review. German.

PMID:
16607488
31.

The Legionella pneumophila global regulatory protein LetA affects DotA and Mip.

Shi C, Forsbach-Birk V, Marre R, McNealy TL.

Int J Med Microbiol. 2006 Feb;296(1):15-24. Epub 2005 Oct 19.

PMID:
16423685
32.

Antibiotic resistant fecal isolates of Enterococci among unselected patients outside the clinical sector: an epidemiological study from Southern Germany.

Lietzau S, Hoewner M, von Baum H, Marre R, Brenner H.

Pharmacoepidemiol Drug Saf. 2006 Apr;15(4):275-7.

PMID:
16287198
33.

Antimicrobial resistance of Escherichia coli and therapeutic implications.

von Baum H, Marre R.

Int J Med Microbiol. 2005 Oct;295(6-7):503-11. Review.

PMID:
16238024
34.

[New therapeutic strategies for community acquired pneumonia].

Welte T, Marre R, Suttorp N.

Internist (Berl). 2005 Dec;46(12):1354-9. Review. German.

PMID:
16231169
35.

Chlamydia pneumoniae in an ex vivo human artery culture model.

Poppert S, Schlaupitz K, Marre R, Voisard R, Roessler W, Weckermann D, Weingärtner K, Essig A.

Atherosclerosis. 2006 Jul;187(1):50-6. Epub 2005 Sep 30.

PMID:
16202418
36.

[S3-guideline on ambulant acquired pneumonia and deep airway infections].

Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, Dietrich E, Ewig S, Gastmeier P, Grabein B, Halle E, Kolditz M, Marre R, Sitter H.

Pneumologie. 2005 Sep;59(9):612-64. German. No abstract available.

PMID:
16170727
37.

Impact of fluoroquinolone prophylaxis on reduced infection-related mortality among patients with neutropenia and hematologic malignancies.

Reuter S, Kern WV, Sigge A, Döhner H, Marre R, Kern P, von Baum H.

Clin Infect Dis. 2005 Apr 15;40(8):1087-93. Epub 2005 Mar 11.

PMID:
15791505
38.

Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.

Kern WV, Klose K, Jellen-Ritter AS, Oethinger M, Bohnert J, Kern P, Reuter S, von Baum H, Marre R.

Eur J Clin Microbiol Infect Dis. 2005 Feb;24(2):111-8.

PMID:
15714332
39.
40.
41.
42.

CAPNETZ-community-acquired pneumonia competence network.

Welte T, Suttorp N, Marre R.

Infection. 2004 Aug;32(4):234-8. No abstract available.

PMID:
15293080
43.

Update on glycopeptide use in german university hospitals.

Kern WV, De With K, Gonnermann C, Strehl E, Bergner J, Höffken G, Dörje F, Daschner F, Steib-Bauert M, Haber M, Herrmann M, Hartmann M, Straube E, Bühner R, Rothe U, Salzberger B, Marre R, Kern P; Medical Antibiotic Use Surveillance and Evaluation.

Infection. 2004 Jun;32(3):157-62.

PMID:
15188076
44.
45.

Algorithm for the identification of bacterial pathogens in positive blood cultures by real-time LightCycler polymerase chain reaction (PCR) with sequence-specific probes.

Wellinghausen N, Wirths B, Franz AR, Karolyi L, Marre R, Reischl U.

Diagn Microbiol Infect Dis. 2004 Apr;48(4):229-41.

PMID:
15062914
46.

[Competence network "community acquired pneumonia" (CAPNETZ). A first interim report].

Welte T, Marre R, Suttorp N.

Internist (Berl). 2004 Apr;45(4):393-401. German.

PMID:
15024468
47.

Chronic granulomatous lung infection caused by the dimorphic fungus Emmonsia sp.

Wellinghausen N, Kern WV, Haase G, Rozdzinski E, Kern P, Marre R, Essig A, Hetzel J, Hetzel M.

Int J Med Microbiol. 2003 Dec;293(6):441-5.

PMID:
14760976
49.
50.

[SARS--Severe Acute Respiratory syndrome].

Tuschy P, Welte T, Marre R, Suttorp N, Lorenz J, Fätkenheuer G, Ewig S.

Pneumologie. 2003 May;57(5):256-8. German. No abstract available.

PMID:
12784177

Supplemental Content

Support Center